Brainsway (BWAY) Equity Ratio (2018 - 2025)

Brainsway posted quarterly Equity Ratio of 0.65 for Q4 2025, down 2.17% year-on-year from 0.66 in Q4 2024, and down 2.17% on a QoQ basis from 0.66 in Q4 2024.

Brainsway (BWAY) has 8 years of Equity Ratio data on file, last reported at 0.65 in Q4 2025.

  • For the quarter ending Q4 2025, Equity Ratio fell 2.17% year-over-year to 0.65; the trailing twelve-month figure through Dec 2025 stood at 0.65 (down 2.17% YoY), and the FY2025 full-year result was 0.65, down 2.17% from the prior year.
  • Equity Ratio for Q4 2025 stood at 0.65, down from 0.66 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.76 in Q4 2021 and bottomed at 0.65 in Q4 2025.
  • The 5-year median for Equity Ratio is 0.66 (2024), against an average of 0.69.
  • The widest annual swing landed in 2021, when Equity Ratio surged 31.12%; it then decreased 6.98% in 2022.
  • A 5-year view of Equity Ratio shows it stood at 0.76 in 2021, then slipped by 6.98% to 0.7 in 2022, then decreased by 6.22% to 0.66 in 2023, then grew by 0.06% to 0.66 in 2024, then decreased by 2.17% to 0.65 in 2025.
  • The last three Equity Ratio figures came in at 0.65 (Q4 2025), 0.66 (Q4 2024), and 0.66 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.47
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.50
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.54
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.59
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.78
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.45
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.29
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.67
10 Brainsway 6.80 Mn -52.98 Mn 11.68 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 0.65
Dec 31, 2024 0.66
Dec 31, 2023 0.66
Dec 31, 2022 0.70
Dec 31, 2021 0.76
Dec 31, 2020 0.58
Dec 31, 2019 0.63
Dec 31, 2018 0.29